CatalyScope tracks upcoming clinical trial milestones across the global pharmaceutical and biotechnology landscape. Using our Hidden Helix pipeline — which integrates real-time data from public clinical trial registries and applies AI-assisted analysis — we identify when primary endpoint readouts are expected to occur.

Drug development is complex and non-linear. Clinical trial outcomes play a central role in determining whether a therapy advances, changes direction, or concludes. CatalyScope provides structured summaries of trial design, timelines, company pipelines, historical phase transition probabilities, research interest, condition market size and competition landscape, helping users follow the clinical development process with clarity and context.

Currently we focus on Phase 3 trials in the United States but this will be expanded in the near future- Watch this space!

Hidden Helix runs automatically once a month. Trials are included upto 1 year in the past from the date the program was run. The results from the last run are displayed here.